Related Experiment Videos
Treatment intensification in disseminated germ-cell tumors
J Beyer1, C Bokemeyer, H J Schmoll
1Abteilung für Hämatologie/Onkologie, Universitätsklinikum Rudolf Virchow der Freien Universität Berlin, Germany.
Abstract:
Despite major improvements in the treatment of germ cell tumors the results remain unsatisfactory in patients with "poor risk" initial presentation, with inadequately responding or relapsed disease. The alternating use of noncrossresistant drugs or dose-intensified treatment regimens have not proved to be superior to conventional regimens, although the role of early treatment intensification with the use of hematopoetic growth factors or hematopoetic stem cell reinfusion warrants further investigation. In phase I/II trials patients considered incurable with conventional treatment regimens have been successfully salvaged by high-dose chemotherapy and autologous stem cell reinfusion. Several phase III trials to define the role of this novel approach are planned or ongoing in the USA and Europe.
Insights
High-dose chemotherapy with stem cell rescue shows promise for incurable germ cell tumors. Further phase III trials are needed to confirm its effectiveness in poor-risk patients.
Area of Science:
- Oncology
- Hematology
Background:
- Germ cell tumor treatments have improved, but outcomes for poor-risk patients remain poor.
- Conventional and dose-intensified regimens show limited success in advanced or relapsed cases.
Purpose of the Study:
- To investigate the efficacy of high-dose chemotherapy and autologous stem cell reinfusion in patients with refractory germ cell tumors.
- To evaluate a novel approach for patients considered incurable by standard treatments.
Main Methods:
- Phase I/II clinical trials were conducted.
- Patients received high-dose chemotherapy followed by autologous stem cell reinfusion.
- Ongoing and planned Phase III trials aim to validate these findings.
Main Results:
- High-dose chemotherapy with autologous stem cell reinfusion successfully salvaged patients with previously incurable germ cell tumors.
- This approach offers a potential treatment option for refractory disease.
Conclusions:
- High-dose chemotherapy and autologous stem cell reinfusion represent a promising salvage strategy for advanced germ cell tumors.
- Further large-scale Phase III trials are essential to establish the definitive role of this intensive treatment in clinical practice.